Skip to main content

Table 2 Summary of National Surveillance Data of HIV Biomarkers

From: High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review

Country Report Information

Coverage

Pre Implementation and Expansion

Post Implementation and Expansion

Investigators

Location

Surveillance Method

Syringes per PWID/Year1

Year

Baseline HIV cases (n)

Year

Follow-up2HIV cases (n) (Percent Change)

CDC 2007 [32]

Iran

National Surveillance Data

4-41

2003

2332

2007

426 (82%)

Astrauskiene 2010 [33]

Lithuania

National Surveillance Data

56-98

2005

85

2009

117 (+38%)

CDC 2010 [34]

Taiwan

National Surveillance Data

7-67

2006

1693

2010

114 (93%)

Hammett 2010 [35]

Vietnam

National Surveillance Data

9-52

2005

11358

2009

7947 (30%)

  1. 1. Syringes per PWID/Year are given as a range based on the first and last date of data collection in respective study.
  2. 2. Post Implementation columns include follow-up biomarker information in addition to the difference from baseline to follow-up.